HomeCompareWINKF vs MRK

WINKF vs MRK: Dividend Comparison 2026

WINKF yields 11695.91% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WINKF wins by $258587110235347584.00M in total portfolio value
10 years
WINKF
WINKF
● Live price
11695.91%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$258587110235347584.00M
Annual income
$254,309,836,448,839,880,000,000.00
Full WINKF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — WINKF vs MRK

📍 WINKF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWINKFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WINKF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WINKF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WINKF
Annual income on $10K today (after 15% tax)
$994,152.05/yr
After 10yr DRIP, annual income (after tax)
$216,163,360,981,513,900,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, WINKF beats the other by $216,163,360,981,513,900,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WINKF + MRK for your $10,000?

WINKF: 50%MRK: 50%
100% MRK50/50100% WINKF
Portfolio after 10yr
$129293555117673792.00M
Annual income
$127,154,918,224,419,940,000,000.00/yr
Blended yield
98.35%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

WINKF
No analyst data
Altman Z
-99.3
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WINKF buys
0
MRK buys
0
No recent congressional trades found for WINKF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWINKFMRK
Forward yield11695.91%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$258587110235347584.00M$56.8K
Annual income after 10y$254,309,836,448,839,880,000,000.00$9,798.13
Total dividends collected$258303186022416896.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: WINKF vs MRK ($10,000, DRIP)

YearWINKF PortfolioWINKF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$1,180,291$1,169,590.64$11,206$366.19+$1.17MWINKF
2$130,277,574$129,014,662.87$12,650$502.35+$130.26MWINKF
3$13,448,107,932$13,308,710,927.97$14,407$694.19+$13448.09MWINKF
4$1,298,326,546,024$1,283,937,070,536.85$16,585$967.82+$1298326.53MWINKF
5$117,235,654,507,869$115,846,445,103,623.60$19,342$1,363.89+$117235654.49MWINKF
6$9,901,746,408,432,552$9,776,304,258,109,132.00$22,913$1,947.19+$9901746408.41MWINKF
7$782,285,128,477,152,800$771,690,259,820,129,900.00$27,662$2,823.89+$782285128477.13MWINKF
8$57,815,742,378,616,860,000$56,978,697,291,146,306,000.00$34,159$4,173.35+$57815742378616.82MWINKF
9$3,997,452,136,923,100,000,000$3,935,589,292,577,980,000,000.00$43,337$6,308.80+$3997452136923100.00MWINKF
10$258,587,110,235,347,600,000,000$254,309,836,448,839,880,000,000.00$56,776$9,798.13+$258587110235347584.00MWINKF

WINKF vs MRK: Complete Analysis 2026

WINKFStock

Windfall Geotek Inc. develops platforms for the mining sector. The company offers computer aided resource detection system, a platform to analyze digital data sets of georeferenced historical exploration data, including geological, geochemical, geophysical, structural, and digital elevation data; and data mining services. It also acquires, explores for, and develops mineral resource properties in Québec. The company has an option agreement to hold 90% undivided interest in the Chapais project that comprises 36 claims located in Quebec; and 95% undivided interest in the Corallen Lake property that comprises 348 claims. It also owns 5,240 claims in the province of Ontario; 1,078 claims in the province of Quebec; and 11 claims in the province of New Brunswick. The company was formerly known as Albert Mining Inc. and changed its name to Windfall Geotek Inc. in October 2019. Windfall Geotek Inc. was incorporated in 1996 and is headquartered in Brossard, Canada.

Full WINKF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this WINKF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WINKF vs SCHDWINKF vs JEPIWINKF vs OWINKF vs KOWINKF vs MAINWINKF vs JNJWINKF vs ABBVWINKF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.